Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41